Literature DB >> 23545883

Use of cidofovir in recurrent respiratory papillomatosis.

Marco Carifi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23545883     DOI： 10.1007/s00405-013-2456-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  9 in total

1.  [Usefulness of topical cidofovir treatment for recalcitrant molluscum contagiosum in immunocompromised children].

Authors:  M Guérin; V Lepêcheur; P Rachieru-Sourisseau; Y Réguerre; I Pellier; L Martin
Journal:  Arch Pediatr       Date:  2012-10-01       Impact factor: 1.180

2.  Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation.

Authors:  S Cesaro; M Pillon; G Tridello; M Aljurf; R Martino; W Schroyens; C Nozzoli; P Barba; M Faraci; F Fagioli; B Cappelli; C Cordonnier; F Al-Mohareb; Y Floisand; J Greil; I S Panizzolo; S Santarone
Journal:  Bone Marrow Transplant       Date:  2012-12-10       Impact factor: 5.483

3.  Optimal management of cytomegalovirus retinitis in patients with AIDS.

Authors:  Michael W Stewart
Journal:  Clin Ophthalmol       Date:  2010-04-26

4.  Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.

Authors:  M Graupp; M Gugatschka; K Kiesler; E Reckenzaun; G Hammer; G Friedrich
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-16       Impact factor: 2.503

5.  Current use of intralesional cidofovir for recurrent respiratory papillomatosis.

Authors:  Craig S Derkay; Peter G Volsky; Clark A Rosen; Seth M Pransky; J Scott McMurray; Neil K Chadha; Patrick Froehlich
Journal:  Laryngoscope       Date:  2012-10-15       Impact factor: 3.325

6.  Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts.

Authors:  Paolo Broganelli; Antonella Chiaretta; Barbara Fragnelli; Maria Grazia Bernengo
Journal:  Dermatol Ther       Date:  2012 Sep-Oct       Impact factor: 2.851

7.  Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.

Authors:  J Scott McMurray; Nadine Connor; Charles N Ford
Journal:  Ann Otol Rhinol Laryngol       Date:  2008-07       Impact factor: 1.547

8.  Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.

Authors:  Carlos E Araya; Judy F Lew; Robert S Fennell; Richard E Neiberger; Vikas R Dharnidharka
Journal:  Pediatr Transplant       Date:  2006-02

Review 9.  Recurrent respiratory papillomatosis: a review.

Authors:  Craig S Derkay; Brian Wiatrak
Journal:  Laryngoscope       Date:  2008-07       Impact factor: 3.325
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.